Bausch Health Companies (TSE:BHC) Stock Price Down 5.1% – Time to Sell?

Bausch Health Companies Inc. (TSE:BHC) shares were down 5.1% on Friday . The stock traded as low as C$7.28 and last traded at C$7.58. Approximately 297,421 shares traded hands during trading, an increase of 2% from the average daily volume of 290,720 shares. The stock had previously closed at C$7.99.

Bausch Health Companies Price Performance

The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. The stock has a market capitalization of C$1.97 billion, a PE ratio of -11.09, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. The stock’s 50 day moving average is C$9.90 and its two-hundred day moving average is C$10.80.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.